Immunic Inc (IMUX) stock is currently valued at $0.92. During the last session, the stock experienced a remarkable rise, reaching $10.0 after opening at $0.92. The stock briefly dropped to $4.0 before ultimately closing at $0.83.
Immunic Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $2.11 on 09/19/24 and a low of $0.56 for the same time frame on 05/29/25.
52-week price history of IMUX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Immunic Inc’s current trading price is -56.56% away from its 52-week high, while its distance from the 52-week low is 63.37%. The stock’s price range during this period has spanned from $0.56 to $2.11. In the Healthcare sector, the Immunic Inc’s shares surpassed a trading volume of approximately 1.57 million for the day, which was noticeably lower compared to the average daily volume of 9.1.65 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Immunic Inc (IMUX) has experienced a quarterly decline of -6.21% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 90.41M and boasts a workforce of 91 employees.
A Closer Look at Analysts’ Ratings for Immunic Inc
As of right now, 5 analysts are rating Immunic Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9282, with a change in price of -0.2335. Similarly, Immunic Inc recorded 1,442,194 in trading volume during the last 100 days, posting a change of -20.30%.
Examining IMUX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for IMUX stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
IMUX Stock Stochastic Average
Today, Immunic Inc’s raw stochastic average for the past 50 days stands at 47.60%, indicating a rise from the raw stochastic average of the last 20 days, which was 30.66%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 15.73% and 11.71% respectively.
IMUX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -31.09%. However, over the last six months, the performance has been stronger by -2.29%. The price of IMUX increased 2.31% over the last 30 days. And in the last five days, it has surged by 1.57%.
